Approaches for prevention of tumors in patients with rhabdoid tumor predisposition syndromeAnupa Geethadevi, Eric H. Raabe|Neuro-Oncology Advances|2024Cited by 3
The CoREST complex inhibitor, corin, leads to decreased tumor growth, increased cellular differentiation and extended lifespan in atypical teratoid rhabdoid tumor xenograft modelsAnupa Geethadevi, Rhoda M. Alani, Nikhil Vaidya et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1
ATRT-04. TARGETING THE COREST COMPLEX HELPS REPROGRAM AT/RT’S ABNORMAL EPIGENETIC LANDSCAPE TOWARD A DIFFERENTIATION PHENOTYPEAnupa Geethadevi, Jeffrey Rubens, Kristen Malebranche et al.|Neuro-Oncology|2023Cited by 1
Abstract 6498: MEK inhibitor mirdametinib suppresses MAP kinase pathway activity and inhibits tumor growth in atypical teratoid/rhabdoid tumorsYiming Deng, Eric H. Raabe, Kristen Malebranche et al.|Cancer Research|2024Cited by 1
CoREST Complex Inhibition Alters RNA Splicing to Promote Neoantigen Expression and Enhance Tumor ImmunityRobert Fisher, Rhoda M. Alani, Kihyun Park et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1